Mitral Transcatheter Edge-to-edge Repair: British Cardiovascular Intervention Society Position Statement

Transcatheter mitral leaflet repair is a non-surgical technique used to treat severe mitral regurgitation. The technique has matured significantly since its commercial introduction, and with device iteration and increasing operator experience, it is now an important treatment option for patients at higher risk for conventional mitral valve surgery. Randomised clinical trials have established the safety and efficacy of the technique in the treatment of primary and secondary mitral regurgitation, and its use was approved by the National Institute for Health and Care Excellence in 2019. This position statement summarises the clinical evidence and indications for the procedure and provides expert consensus on best practice in terms of patient selection, the procedure and post-procedure care. Standards are also described with respect to team composition, minimum case volume and collection of procedural and outcome data.

Authors

Institutions

Publication Details

Journal
Interventional Cardiology Reviews Research Resources
Published
2025-04-07
DOI
https://doi.org/10.15420/icr.2025.01
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mitral Transcatheter Edge-to-edge Repair: British Cardiovascular Intervention Society Position Statement

Michael J. Mullen, Jim Newton, Mamta Buch, Alison Duncan et al.
Interventional Cardiology Reviews Research Resources
Cardiac Valve Diseases and Treatments
article

Mitral Transcatheter Edge-to-edge Repair: British Cardiovascular Intervention Society Position Statement

Michael J. Mullen, Jim Newton, Mamta Buch, Alison Duncan, Sam Dawkins, Jonathan Byrne, Rob Smith, Tiffany Patterson, Angie Ghattas, Daniel J. Blackman, Adnan Nadir, David Hildick‐Smith
article en

Abstract

Transcatheter mitral leaflet repair is a non-surgical technique used to treat severe mitral regurgitation. The technique has matured significantly since its commercial introduction, and with device iteration and increasing operator experience, it is now an important treatment option for patients at higher risk for conventional mitral valve surgery. Randomised clinical trials have established the safety and efficacy of the technique in the treatment of primary and secondary mitral regurgitation, and its use was approved by the National Institute for Health and Care Excellence in 2019. This position statement summarises the clinical evidence and indications for the procedure and provides expert consensus on best practice in terms of patient selection, the procedure and post-procedure care. Standards are also described with respect to team composition, minimum case volume and collection of procedural and outcome data.

Interventional Cardiology Reviews Research ResourcesVol. 20
St Bartholomew's Hospital (GB), University of Leeds (GB), Guy's and St Thomas' NHS Foundation Trust (GB), Queen Elizabeth Hospital Birmingham (GB), Leeds Teaching Hospitals NHS Trust (GB), Royal Brompton & Harefield NHS Foundation Trust (GB), John Radcliffe Hospital (GB), Jubilee Hospital (GB), Manchester University NHS Foundation Trust (GB), King's College Hospital NHS Foundation Trust (GB), University Hospitals Sussex NHS Foundation Trust (GB)
Abbott Laboratories, Edwards Lifesciences, Boston Scientific Corporation, JenaValve, Abbott Vascular
Good health and well-being
Openalex Percentile: Top 88%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.